Molecular Mechanisms in Progressive Idiopathic Pulmonary Fibrosis

被引:90
|
作者
Steele, Mark P. [1 ]
Schwartz, David A. [2 ,3 ]
机构
[1] Vanderbilt Univ, Sch Med, Lung Transplant Program, Div Allergy Pulm & Crit Care Med, Nashville, TN 37332 USA
[2] Univ Colorado, Sch Med, Aurora, CO 80045 USA
[3] Natl Jewish Hlth, Ctr Genes Environm & Hlth, Denver, CO 80206 USA
来源
ANNUAL REVIEW OF MEDICINE, VOL 64 | 2013年 / 64卷
关键词
familial pulmonary fibrosis; familial interstitial pneumonia; telomerase; surfactant proteins; mucin; 5B; SURFACTANT-PROTEIN-C; NONSPECIFIC INTERSTITIAL PNEUMONIA; ENDOPLASMIC-RETICULUM STRESS; ALVEOLAR EPITHELIAL-CELLS; DYSKERATOSIS-CONGENITA; GENE; MUTATIONS; DISEASE; RISK; SUSCEPTIBILITY;
D O I
10.1146/annurev-med-042711-142004
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
There is clear evidence that environmental exposures and genetic predisposition contribute to the pathogenesis of idiopathic pulmonary fibrosis (IPF). Cigarette smoking increases the risk of developing IPF several-fold, as do other exposures such as metal-fume and wood-dust exposure. Occupations that increase the risk of IPF are agricultural work, hairdressing, and stone polishing, supporting the role of environmental exposure in disease pathogenesis. Genetic predisposition to IPF is evident from its familial aggregation and the fact that pulmonary fibrosis develops in several rare genetic disorders. Mutations in surfactant proteins lead to pulmonary fibrosis and are associated with endoplasmic reticulum stress in alveolar type II epithelial cells. Mutations in telomerase have been found in several families with IPF, and shortened telomeres are found in sporadic cases of IPF. A common variant in mucin 5B predisposes to both familial and sporadic IPF and is present in the majority of cases, indicating sporadic IPF occurs in those with genetic predisposition.
引用
收藏
页码:265 / 276
页数:12
相关论文
共 50 条
  • [31] A UNIQUE BIOMARKER SIGNATURE FOR PROGRESSIVE IDIOPATHIC PULMONARY FIBROSIS
    Clynick, B.
    Corte, T.
    Jo, H.
    Stewart, I
    Glaspole, I
    Grainge, C.
    Maher, T.
    Walters, E.
    Hopkins, P.
    Reynolds, P.
    Chapman, S.
    Zappala, C.
    Keir, G.
    Cooper, W.
    Mahar, A.
    Ellis, S.
    Goh, N.
    De Jong, E.
    Cha, L.
    Tan, D.
    Leigh, L.
    Oldmeadow, C.
    Jenkins, R.
    Moodley, Y.
    RESPIROLOGY, 2021, 26 : 109 - 109
  • [32] 2022 update on clinical practice guidelines for idiopathic pulmonary fibrosis and progressive pulmonary fibrosis
    Tzilas, Vasilios
    Tzouvelekis, Argyrios
    Ryu, Jay H.
    Bouros, Demosthenes
    LANCET RESPIRATORY MEDICINE, 2022, 10 (08): : 729 - 731
  • [33] A Unique Biomarker Signature for Progressive Idiopathic Pulmonary Fibrosis
    Jo, H.
    Corte, T. J.
    Clynick, B.
    Glaspole, I.
    Grainge, C.
    Jenkins, R. G.
    Stewart, I.
    Maher, T. M.
    Walters, E. H.
    Hopkins, P.
    Reynolds, P. N.
    Chapman, S.
    Zappala, C. J.
    Keir, G. J.
    Cooper, W.
    Maher, A.
    Ellis, S.
    Goh, N.
    De Jong, E.
    Cha, L.
    Tan, D.
    Leigh, L.
    Oldmeadow, C.
    Moodley, Y. I.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [34] A Unique Biomarker Signature for Progressive Idiopathic Pulmonary Fibrosis
    Clynick, B.
    Corte, T. J.
    Jo, H. E.
    Glaspole, I. N.
    Grainge, C.
    Jenkins, G.
    Stewart, I.
    Maher, T. M.
    Walters, E.
    Hopkins, P. M. A.
    Reynolds, P. N.
    Chapman, S.
    Zappala, C.
    Keir, G. J.
    Cooper, W. A.
    Mahar, A. M.
    Ellis, S.
    Goh, N.
    De Jong, E.
    Cha, L.
    Tan, D. B. A.
    Leigh, L.
    Oldmeadow, C.
    Moodley, Y.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [35] Novel Mechanisms and Treatment of Idiopathic Pulmonary Fibrosis
    Elmufdi, Firas
    Henke, Craig A.
    Perlman, David M.
    Tomic, Rade
    Kim, Hyun Joo
    DISCOVERY MEDICINE, 2015, 20 (109) : 145 - 153
  • [36] The pathogenetic mechanisms of cough in idiopathic pulmonary fibrosis
    Bargagli, Elena
    Di Masi, Maria
    Perruzza, Marco
    Vietri, Lucia
    Bergantini, Laura
    Torricelli, Elena
    Biadene, Giulia
    Fontana, Giovanni
    Lavorini, Federico
    INTERNAL AND EMERGENCY MEDICINE, 2019, 14 (01) : 39 - 43
  • [37] The pathogenetic mechanisms of cough in idiopathic pulmonary fibrosis
    Elena Bargagli
    Maria Di Masi
    Marco Perruzza
    Lucia Vietri
    Laura Bergantini
    Elena Torricelli
    Giulia Biadene
    Giovanni Fontana
    Federico Lavorini
    Internal and Emergency Medicine, 2019, 14 : 39 - 43
  • [38] Pathogenic Mechanisms Underlying Idiopathic Pulmonary Fibrosis
    Moss, Benjamin J.
    Ryter, Stefan W.
    Rosas, Ivan O.
    ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE, 2022, 17 : 515 - 546
  • [39] Molecular Phenotypes Distinguish Patients with Relatively Stable from Progressive Idiopathic Pulmonary Fibrosis (IPF)
    Boon, Kathy
    Bailey, Nathaniel W.
    Yang, Jun
    Steel, Mark P.
    Groshong, Steve
    Kervitsky, Dolly
    Brown, Kevin K.
    Schwarz, Marvin I.
    Schwartz, David A.
    PLOS ONE, 2009, 4 (04):
  • [40] Research Progress in the Molecular Mechanisms, Therapeutic Targets, and Drug Development of Idiopathic Pulmonary Fibrosis
    Ma, Hongbo
    Wu, Xuyi
    Li, Yi
    Xia, Yong
    FRONTIERS IN PHARMACOLOGY, 2022, 13